Knygos.lt klubas Knygos.lt nariams
175,27 €
-30%
Įprastai
250,39 €
Trends in Drug Discovery in Diabetes and Obesity
Trends in Drug Discovery in Diabetes and Obesity
Knygos.lt klubas Knygos.lt nariams
175,27 €
-30%
Įprastai
250,39 €
  • Planuojame turėti už 124 d.
Intended as an introduction for scientists and professionals working in drug discovery and deveopment, the first part of the book reviews recent therapy developments in diabetes and obesity treatment. The second part survey important drug classes, including both peptide drugs and small molecule drugs such as GLP-1 receptor agonists, GIP antagonists and poly-agonists. The last part of the book is devoted to selected case studies which provide insights into the discovery of recently approved drug…
  • Leidėjas:
  • Metai: 2026
  • Puslapiai: 320
  • ISBN-10: 3527353305
  • ISBN-13: 9783527353309
  • Kalba: Anglų

Trends in Drug Discovery in Diabetes and Obesity (el. knyga) (skaityta knyga) | knygos.lt

Atsiliepimai

Aprašymas

Intended as an introduction for scientists and professionals working in drug discovery and deveopment, the first part of the book reviews recent therapy developments in diabetes and obesity treatment.
The second part survey important drug classes, including both peptide drugs and small molecule drugs such as GLP-1 receptor agonists, GIP antagonists and poly-agonists. The last part of the book is devoted to selected case studies which provide insights into the discovery of recently approved drugs.

Knygos.lt klubas
Knygos.lt nariams
175,27 €
-30%
Įprastai
250,39 €
Kaina registruotiems pirkėjams
Prisijunkite ir už šią prekę
gausite 2,50 Knygų Eurų!?
Planuojame turėti už 124 d.
Įsigykite dovanų kuponą
Daugiau
  • Leidėjas:
  • Metai: 2026
  • Puslapiai: 320
  • ISBN-10: 3527353305
  • ISBN-13: 9783527353309
  • Kalba: Anglų

Intended as an introduction for scientists and professionals working in drug discovery and deveopment, the first part of the book reviews recent therapy developments in diabetes and obesity treatment.
The second part survey important drug classes, including both peptide drugs and small molecule drugs such as GLP-1 receptor agonists, GIP antagonists and poly-agonists. The last part of the book is devoted to selected case studies which provide insights into the discovery of recently approved drugs.

Atsiliepimai

  • Atsiliepimų nėra
0 pirkėjai įvertino šią prekę.
5
0%
4
0%
3
0%
2
0%
1
0%
(rodomas nebus)
[{"option":"222","probability":1,"style":{"backgroundColor":"#ffffff"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba631ba76d1782294065.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}},{"option":"221","probability":1.3,"style":{"backgroundColor":"#e1032e"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba61ea9f381782294046.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}},{"option":"220","probability":1.6,"style":{"backgroundColor":"#ffffff"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba60167d251782294017.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}},{"option":"219","probability":1.5,"style":{"backgroundColor":"#e2022e"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba5ea1c47d1782293994.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}},{"option":"218","probability":1.5,"style":{"backgroundColor":"#ffffff"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba5d38b4a21782293971.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}},{"option":"217","probability":1.6,"style":{"backgroundColor":"#e3022e"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba5b981b7a1782293945.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}},{"option":"216","probability":1.4,"style":{"backgroundColor":"#ffffff"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba58b535551782293899.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}},{"option":"215","probability":0.1,"style":{"backgroundColor":"#ffe01a"},"image":{"uri":"\/uploads\/images\/wheel_of_fortune\/6a3ba53a6496f1782293818.png","sizeMultiplier":0.6,"landscape":true,"offsetX":-50}}]